Anti-inflammatory effects of rebamipide according to Helicobacter pylori status in patients with chronic erosive gastritis: A randomized sucralfate-controlled multicenter trial in China - STARS study

Digestive Diseases and Sciences

Volumn 53, Issue 11, 2008, Pages 2886-2895

  Du, Yiqi ^a   Li, Zhaoshen ^a   Zhan, Xianbao ^a   Chen, Jie ^a   Gao, Jun ^a   Gong, Yanfang ^a   Ren, Jianlin ^b   He, Liping ^c   Zhang, Zhijian ^d   Guo, Xiaozhong ^e   Wu, Jianshen ^f   Tian, Zibin ^g   Shi, Ruihua ^h   Jiang, Bo ⁱ   Fang, Dianchun ^j   Li, Youming ^k  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

^c FUJIAN PROVINCIAL HOSPITAL   (China)

^d FUZHOU GENERAL HOSPITAL   (China)

^e GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^f WENZHOU MEDICAL UNIVERSITY   (China)

^g QINGDAO UNIVERSITY   (China)

^h NANJING MEDICAL UNIVERSITY   (China)

ⁱ SOUTHERN MEDICAL UNIVERSITY   (China)

^j THIRD MILITARY MEDICAL UNIVERSITY   (China)

^k ZHEJIANG UNIVERSITY   (China)

more..

Author keywords

Chronic erosive gastritis; Gastroprotection; Helicobacter pylori; Rebamipide

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; MALONALDEHYDE; OMEPRAZOLE; PROSTAGLANDIN E2; REBAMIPIDE; SHU KE FEI; SUCRALFATE; UNCLASSIFIED DRUG;

ACUTE APPENDICITIS; ADULT; AGED; ARTICLE; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DRUG EFFECT; DRUG SAFETY; DRUG WITHDRAWAL; ENDOSCOPIC ECHOGRAPHY; EROSIVE GASTRITIS; FEMALE; GASTROINTESTINAL SYMPTOM; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SCORING SYSTEM; STOMACH MUCOSA; STOMATITIS; TREATMENT RESPONSE; VOMITING;

ADULT; ALANINE; ANTI-INFLAMMATORY AGENTS; ANTI-ULCER AGENTS; CHINA; DINOPROSTONE; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; QUINOLONES; SUCRALFATE;

EID: 53849090964     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-0180-z     Document Type: Article

References (32)

1. T Arakawa K Kobayashi T Yoshikawa A Tarnawski 1998 Rebamipide, overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing Dig Dis Sci 43 5S 13S
2. T Arakawa K Higuchi Y Fujiwara T Watanabe K Tominaga E Sasaki N Oshitani T Yoshikawa AS Tarnawski 2005 15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications Dig Dis Sci 50 3S 11S
3. RM Genta 2003 Review article: the role of rebamipide in the management of inflammatory disease of the gastrointestinal tract Aliment Pharmacol Ther 18 8S 13S
4. H Murata Y Yabe S Tsuji M Tsujii HY Fu K Asahi H Eguchi S Kawano N Hayashi 2005 Gastro-protective agent rebamipide induces cyclooxygenease-2 (COX-2) in gastric epithelial cells Dig Dis Sci 50 70S 75S
5. K Sakurai T Osaka K Yamasaki 2005 Rebamipide reduces recurrence of experimental gastric ulcers: role of free radicals and neutrophils Dig Dis Sci 50 90S 96S
6. T Azuma S Yamazaki A Yamakawa Y Ito M Ohtani M Dojo Y Yamazaki H Higashi M Hatakeyama 2003 The effects of cure of Helicobacter pylori infection on the signal transduction of gastric epithelial cells Aliment Pharmacol Ther 18 39S 44S
7. N Yoshida T Ishikawa E Ichiishi Y Yoshida K Hanashiro M Kuchide K Uchiyama S Kokura H Ichikawa Y Naito Y Yamamura T Okanoue T Yoshikawa 2003 The effect of rebamipide on Helicobacter pylori extract-mediated changes of gene expression in gastric epithelial cells Aliment Pharmacol Ther 18 63S 75S
8. JS Kim JM Kim HC Jung IS Song 2003 The effect of rebamipide on the expression of proinflammatory mediators and apoptosis in human neutrophils by Helicobacter pylori water-soluble surface proteins Aliment Pharmacol Ther 18 45S 54S
9. KB Hahm DH Kim KM Lee JS Lee YJ Surh YB Kim BM Yoo JH Kim HJ Joo YK Cho KT Nam SW Cho 2003 Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice Aliment Pharmacol Ther 18 24S 38S
10. T Fujioka T Arakawa T Shimoyama T Yoshikawa M Itoh M Asaka H Ishii H Kuwayama R Sato S Kawai T Takemoto K Kobayashi 2003 Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicentre trial Aliment Pharmacol Ther 18 146S 152S
11. NJ Talley C Quan 2002 Review article: Helicobacter pylori and nonulcer dyspepsia Aliment Pharmacol Ther 16 58S 65S
12. X Jin YM Li 2007 Systematic review and meta-analysis from Chinese literature: the association between Helicobacter pylori eradication and improvement of functional dyspepsia Helicobacter 12 541 546
13. F Farinati R Cardin P Degan M Rugge FD Mario P Bonvicini R Naccarato 1998 Oxidative DNA damage accumulation in gastric carcinogenesis Gut 42 351 356
14. T Rokkas I Simsek S Ladas 2007 Helicobacter pylori and non-malignant diseases Helicobacter 12 20S 22S
15. M Rugge RM Genta 2005 Staging and grading of chronic gastritis Hum Pathol 36 228 233
16. NJ Talley DS Riff H Schwartz SP Marcuard 2001 Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection Aliment Pharmacol Ther 15 1603 1611
17. T Hiratsuka S Futagami T Shindo T Hamamoto N Ueki K Suzuki Y Shinji M Kusunoki K Shinoki K Wada K Miyake K Gudis T Tsukui C Sakamoto 2005 Rebamipide reduces indomethacin-induced gastric injury in mice via down-regulation of ICAM-1 expression Dig Dis Sci 50 84S 89S
18. Y Nagano H Matsui M Muramatsu O Shimokawa T Shibahara A Yanaka A Nakahara Y Matsuzaki N Tanaka Y Nakamura 2005 Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells Dig Dis Sci 50 76S 83S
19. Y Naito H Kajikawa K Mizushima M Shimozawa M Kuroda K Katada T Takagi O Handa S Kokura H Ichikawa N Yoshida H Matsui T Yoshikawa 2005 Rebamipide, a gastro-protective drug, inhibits indomethacin-induced apoptosis in cultured rat gastric mucosal cells: association with the inhibition of growth arrest and DNA damage-induced 45 alpha expression Dig Dis Sci 50 104S 112S
20. N Harada K Okajima W Liu 2005 Rebamipide decreases the susceptibility of gastric mucosa to acid-induced injury in rats by inhibiting neutrophil activation Dig Dis Sci 50 56S 62S
21. T Hiratsuka S Futagami A Tatsuguchi K Suzuki Y Shinji M Kusunoki K Shinoki H Nishigaki S Fujimori K Wada K Miyake K Gudis T Tsukui C Sakamoto 2005 COX-1 and COX-2 conversely promote and suppress ischemia-reperfusion gastric injury in mice Scand J Gastroenterol 40 903 913
22. H Bamba S Ota A Kato H Miyatani C Kawamoto Y Yoshida K Fujiwara 2003 Effect of rebamipide on prostaglandin receptors-mediated increase of inflammatory cytokine production by macrophages Aliment Pharmacol Ther 18 113S 118S
23. K Sakurai H Sasabe T Koga T Konishi 2004 Mechanism of hydroxyl radical scavenging by rebamipide: identification of mono-hydroxylated rebamipide as a major reaction product Free Radic Res 38 487 494
24. AS Tarnawski J Chai R Pai SK Chiou 2004 Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action? Dig Dis Sci 49 202 209
25. K Haruma M Ito 2003 Review article: clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipide Aliment Pharmacol Ther 18 153S 159S
26. T Matysiak-Budnik M Heyman F Megraud 2003 Review article: rebamipide and the digestive epithelial barrier Aliment Pharmacol Ther 18 55S 62S
27. T Joh Y Takezono T Oshima M Sasaki K Seno Y Yokoyama H Ohara T Nomura JS Alexander M Itoh 2003 The protective effect of rebamipide on paracellular permeability of rat gastric epithelial cells Aliment Pharmacol Ther 18 133S 138S
28. A Terano T Arakawa T Sugiyama T Yoshikawa K Haruma M Asaka T Shimosegawa N Sakaki H Ishii C Sakamoto S Takahashi Y Kinoshita T Fujioka K Kobayashi 2006 A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide J Gastroenterol Hepatol 21 103 109
29. K Higuchi T Tanigawa M Hamaguchi T Takashima E Sasaki M Shiba K Tominaga Y Fujiwara N Oshitani T Matsumoto T Watanabe T Arakawa 2003 Comparison of the effects of rebamipide with those of cimetidine on chronic gastritis associated with Helicobacter pylori in Mongolian gerbils Aliment Pharmacol Ther 18 1S 7S
30. KW Choi YC Lee IS Chung JJ Lee MH Chung NY Kim SW Kim JG Kim IH Roe SW Lee HY Jung MG Choi KB Hahm WS Hong JH Kim 2002 Effect of rebamipide in treatment of Helicobacter pylori-associated duodenal ulcer: attenuation of chemokine expression and nitrosative damage Dig Dis Sci 47 283 291
31. K Adachi H Fujishiro T Mihara Y Komazawa Y Kinoshita 2003 Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection J Gastroenterol Hepatol 18 168 171
32. K Haruma M Ito S Kido 2002 Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis Dig Dis Sci 47 862 867